Contribution of intracellular ATP to cisplatin resistance of tumor cells

Journal of Biological Inorganic Chemistry

Volumn 18, Issue 2, 2013, Pages 165-174

  Schneider, Verena ^a   Krieger, Michaela L ^a   Bendas, Gerd ^a   Jaehde, Ulrich ^a   Kalayda, Ganna V ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

ATP; Cisplatin resistance; Na+,K+ ATPase; Oligomycin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CISPLATIN; OLIGOMYCIN; PLATINUM COMPLEX; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG ACCUMULATION; DRUG TRANSPORT; ENERGY TRANSFER; ENZYME LOCALIZATION; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; OVARY ADENOCARCINOMA; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; INTRACELLULAR FLUID; OLIGOMYCINS; OUABAIN; PROTEIN SUBUNITS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

STROPHANTHUS GRATUS;

EID: 84878843251     PISSN: 09498257     EISSN: 14321327     Source Type: Journal    
DOI: 10.1007/s00775-012-0960-6     Document Type: Article

References (51)

1. Burger H, Loos WJ, Eechoute K, Verweij J, Mathijssen RH, Wiemer EA (2011) Drug Resist Updates 14:22-34
2. Gately DP, Howell SB (1993) Br J Cancer 67:1171-1176
3. Pereira-Maia E, Garnier-Suillerot A (2003) J Biol Inorg Chem 8:626-634
4. Stewart DJ (2007) Crit Rev Oncol Hematol 63:12-31
5. Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM (2008) Annu Rev Pharmacol Toxicol 48:495-535
6. Dobson PD, Lanthaler K, Oliver SG, Kell DB (2009) Curr Top Med Chem 9:163-181
7. Fujii R, Mutoh M, Niwa K, Yamada K, Aikou T, Nakagawa M, Kuwano M, Akiyama S (1994) Jpn J Cancer Res 85:426-433
8. Ma J, Maliepaard M, Kolker HJ, Verweij J, Schellens JH (1998) Cancer Chemother Pharmacol 41:186-192
9. Shen DW, Goldenberg S, Pastan I, Gottesman MM (2000) J Cell Physiol 183:108-116
10. Maymon R, Bar-Shira MB, Cohen-Armon M, Holtzinger M, Leibovici J (1994) Biochim Biophys Acta 1201:173-178
11. Swennen EL, Ummels V, Buss I, Jaehde U, Bast A, Dagnelie PC (2010) Chem Biol Interact 184:338-345
12. Andrews PA, Velury S, Mann SC, Howell SB (1988) Cancer Res 48:68-73
13. Kishimoto S, Kawazoe Y, Ikeno M, Saitoh M, Nakano Y, Nishi Y, Fukushima S, Takeuchi Y (2006) Cancer Chemother Pharmacol 57:84-90
14. Watabe M, Nakaki T (2007) Neuropharmacology 52:536-541
15. Pelicano H, Martin DS, Xu RH, Huang P (2006) Oncogene 25:4633-4646
16. Kalayda GV, Wagner CH, Buss I, Reedijk J, Jaehde U (2008) BMC Cancer 8:175
17. Kalayda GV, Wagner CH, Jaehde U (2012) J Inorg Biochem 116:1-10
18. Zisowsky J, Koegel S, Leyers S, Devarakonda K, Kassack MU, Osmak M, Jaehde U (2007) Biochem Pharmacol 73:298-307
19. Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS, Saprunova VB, Vyssokikh MY, Chernyak BV, Skulachev VP (2002) Oncogene 21:8149-8157
20. Esmann M (1991) Biochim Biophys Acta 1064:31-36
21. Homareda H, Ishii T, Takeyasu K (2000) Eur J Pharmacol 400:177-183
22. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Cancer Res 48:589-601
23. Crouch SP, Kozlowski R, Slater KJ, Fletcher J (1993) J Immunol Methods 160:81-88
24. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Anal Biochem 150:76-85
25. Andrews PA, Mann SC, Huynh HH, Albright KD (1991) Cancer Res 51:3677-3681
26. Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N (1993) Jpn J Cancer Res 84:83-92
27. Kloft C, Appelius H, Siegert W, Schunack W, Jaehde U (1999) Ther Drug Monit 21:631-637
28. Martin DS, Spriggs D, Koutcher JA (2001) Apoptosis 6:125-131
29. Nieminen AL, Saylor AK, Herman B, Lemasters JJ (1994) Am J Physiol 267:C67-C74
30. Schneider V, Kalayda GV, Krieger ML, Bendas G, Jaehde U (2010) Int J Clin Pharmacol Ther 48:456-458
31. Rotte A, Garmann D, Buss I, Jaehde U (2010) Chemotherapy 56:1-8
32. Skou JC, Esmann M (1992) J Bioenerg Biomembr 24:249-261
33. Krieger ML, Eckstein N, Schneider V, Koch M, Royer HD, Jaehde U, Bendas G (2010) Int J Pharm 389:10-17
34. Trincavelli ML, Daniele S, Martini C (2010) Curr Top Med Chem 10:860-877
35. Plesner L, Plesner IW (1991) Biochim Biophys Acta 1076:421-426
36. Andrews PA, Albright KD (1991) In: Howell SB (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Plenum Press, New York, pp 151-159
37. Salerno M, Yahia D, Dzamitika S, de Vries E, Pereira-Maia E, Garnier-Suillerot A (2009) J Biol Inorg Chem 14:123-132
38. Ahmed Z, Deyama Y, Yoshimura Y, Suzuki K (2008) Cancer Chemother Pharmacol 63:643-650
39. Ohmori T, Nishio K, Ohta S, Kubota N, Adachi M, Komiya K, Saijo N (1994) Int J Cancer 57:111-116
40. Huliciak M, Vacek J, Sebela M, Orolinova E, Znaleziona J, Havlikova M, Kubala M (2012) Biochem Pharmacol 83:1507-1513
41. Arato-Oshima T, Matsui H, Wakizaka A, Homareda H (1996) J Biol Chem 271:25604-25610
42. Shen DW, Pouliot LM, Hall MD, Gottesman MM (2012) Pharmacol Rev 64:706-721
43. Safaei R (2006) Cancer Lett 234:34-39
44. Helleman J, Burger H, Hamelers IH, Boersma AW, de Kroon AI, Stoter G, Nooter K (2006) Cancer Biol Ther 5:943-949
45. Choi MK, Song IS (2008) Drug Metab Pharmacokinet 23:243-253
46. Stolfi RL, Colofiore JR, Nord LD, Koutcher JA, Martin DS (1992) Cancer Res 52:4074-4081
47. Zhou Y, Tozzi F, Chen J, Fan F, Xia L, Wang J, Gao G, Zhang A, Xia X, Brasher H, Widger W, Ellis LM, Weihua Z (2012) Cancer Res 72:304-314
48. Balaban RS (1990) Am J Physiol 258:C377-C389
49. Sweet S, Singh G (1999) J Cell Physiol 180:91-96
50. Andrews PA, Albright KD (1992) Cancer Res 52:1895-1901
51. Liang BC, Ullyatt E (1998) Cell Death Differ 5:694-701